E Du

745 total citations
33 papers, 531 citations indexed

About

E Du is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, E Du has authored 33 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Surgery and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in E Du's work include Epigenetics and DNA Methylation (5 papers), Genetic and Kidney Cyst Diseases (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). E Du is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Genetic and Kidney Cyst Diseases (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). E Du collaborates with scholars based in China, United States and United Kingdom. E Du's co-authors include Shiyong Qi, Kuo Yang, Zhihong Zhang, Yue Chen, Yong Xu, Yong Xu, Changwen Zhang, Zhihong Zhang, Xingkang Jiang and Chao Lü and has published in prestigious journals such as Environmental Pollution, Frontiers in Immunology and Experimental Cell Research.

In The Last Decade

E Du

33 papers receiving 528 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E Du China 16 279 117 105 57 55 33 531
Hye Jin Heo South Korea 12 308 1.1× 107 0.9× 65 0.6× 24 0.4× 75 1.4× 36 556
Yan Meng China 12 210 0.8× 90 0.8× 130 1.2× 26 0.5× 42 0.8× 27 521
Shuai Zhao China 14 273 1.0× 100 0.9× 106 1.0× 67 1.2× 173 3.1× 41 669
Xingang Wang China 15 258 0.9× 101 0.9× 52 0.5× 34 0.6× 162 2.9× 44 591
Emilia Vuttariello Italy 13 407 1.5× 131 1.1× 75 0.7× 25 0.4× 118 2.1× 23 742
Huan Qiao United States 14 244 0.9× 94 0.8× 103 1.0× 28 0.5× 127 2.3× 24 600
Shenghang Wang China 12 271 1.0× 179 1.5× 234 2.2× 35 0.6× 65 1.2× 28 694
Ling Jiang China 9 275 1.0× 99 0.8× 71 0.7× 27 0.5× 31 0.6× 17 406

Countries citing papers authored by E Du

Since Specialization
Citations

This map shows the geographic impact of E Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Du more than expected).

Fields of papers citing papers by E Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Du. The network helps show where E Du may publish in the future.

Co-authorship network of co-authors of E Du

This figure shows the co-authorship network connecting the top 25 collaborators of E Du. A scholar is included among the top collaborators of E Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Du. E Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Jie, et al.. (2025). Recent progress in polysaccharide microsphere-based hemostatic material for intravascular and extravascular hemostasis: A review. International Journal of Biological Macromolecules. 300. 140280–140280. 5 indexed citations
2.
Li, Jingxian, et al.. (2025). The combination treatment of RC48 and STAT3 inhibitor acts as a promising therapeutic strategy for basal bladder cancer. Frontiers in Immunology. 15. 1432586–1432586. 2 indexed citations
4.
Li, Bo, Yan Liu, Kuo Yang, et al.. (2023). STIL/AURKA axis promotes cell proliferation by influencing primary cilia formation in bladder cancer. Journal of Translational Medicine. 21(1). 281–281. 9 indexed citations
5.
Zheng, Zhiwen, Juan Ma, E Du, et al.. (2023). Low-dose graphene oxide promotes tumor cells proliferation by activating PI3K-AKT-mTOR signaling via cellular membrane protein integrin αV. Environmental Pollution. 330. 121817–121817. 7 indexed citations
7.
Li, Jingxian, Xun Liu, Yang Liu, et al.. (2022). STIL Acts as an Oncogenetic Driver in a Primary Cilia-Dependent Manner in Human Cancer. Frontiers in Cell and Developmental Biology. 10. 804419–804419. 9 indexed citations
8.
Du, E, Yan Liu, Jun Cheng, et al.. (2020). <p>Anticancer Effects of Zinc Oxide Nanoparticles Through Altering the Methylation Status of Histone on Bladder Cancer Cells</p>. International Journal of Nanomedicine. Volume 15. 1457–1468. 56 indexed citations
9.
Chen, Yue, Meng Wang, E Du, et al.. (2018). Autophagic effects and mechanisms of silver nanoparticles in renal cells under low dose exposure. Ecotoxicology and Environmental Safety. 166. 71–77. 29 indexed citations
10.
Zhang, Changwen, Chao Lü, Zhen Wang, et al.. (2018). Antimony enhances c-Myc stability in prostate cancer via activating CtBP2-ROCK1 signaling pathway. Ecotoxicology and Environmental Safety. 164. 61–68. 17 indexed citations
11.
Zhang, Changwen, Tong Yang, Li Wang, et al.. (2018). Kinase PIM1 promotes prostate cancer cell growth via c-Myc-RPS7-driven ribosomal stress. Carcinogenesis. 40(1). 52–60. 22 indexed citations
12.
Du, E, Changwen Zhang, Kuo Yang, et al.. (2017). Low expression of TMEM67 is a critical predictor of poor prognosis in human urothelial carcinoma of the bladder. Urologic Oncology Seminars and Original Investigations. 35(4). 152.e7–152.e12. 1 indexed citations
13.
Du, E, Lin Wang, Changying Li, et al.. (2017). Analysis of immune status after iodine-125 permanent brachytherapy in prostate cancer. OncoTargets and Therapy. Volume 10. 2561–2567. 11 indexed citations
14.
Jiang, Xingkang, Yue Chen, E Du, et al.. (2016). GATA3-driven expression of miR-503 inhibits prostate cancer progression by repressing ZNF217 expression. Cellular Signalling. 28(9). 1216–1224. 36 indexed citations
15.
Jiang, Xingkang, Chao Lü, Yue Chen, et al.. (2016). The protective role of Nrf2-Gadd45b against antimony-induced oxidative stress and apoptosis in HEK293 cells. Toxicology Letters. 256. 11–18. 32 indexed citations
16.
Liu, Zhifei, Li Wang, Baomin Qiao, et al.. (2015). Prognostic significance of GPC5 expression in patients with prostate cancer. Tumor Biology. 37(5). 6413–6418. 20 indexed citations
17.
Du, E, Hong Li, Shunying Jin, et al.. (2013). Evidence that TMEM67 causes polycystic kidney disease through activation of JNK/ERK‐dependent pathways. Cell Biology International. 37(7). 694–702. 4 indexed citations
18.
Moffatt, Beryl E., James N. Arnold, E Du, et al.. (2013). Purification, Quantification, and Functional Analysis of Complement Factor H. Methods in molecular biology. 1100. 207–223. 5 indexed citations
19.
Qu, Yanchun, E Du, Yue Zhang, et al.. (2012). Changes in the Expression of Bone Morphogenetic Protein 7 and Tamm– Horsfall Protein in the Early Stages of Diabetic Nephropathy. Nephro-Urology Monthly. 4(2). 466–469. 5 indexed citations
20.
Dreixler, John C., Frank C. Barone, Afzhal R. Shaikh, E Du, & Steven Roth. (2009). Mitogen-activated protein kinase p38α and retinal ischemic preconditioning. Experimental Eye Research. 89(5). 782–790. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026